Published in Virology on November 01, 1994
The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J Virol (1996) 3.22
The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J Virol (1997) 2.39
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol (1995) 2.35
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc Natl Acad Sci U S A (2005) 1.95
Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol (2008) 1.63
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 1.58
Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J Virol (2010) 1.35
Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci U S A (2002) 1.33
Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr HIV Res (2010) 1.29
The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J Virol (1998) 1.20
Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol (2004) 1.14
Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J Virol (1996) 1.06
Molecular mechanisms of FIV infection. Vet Immunol Immunopathol (2008) 1.02
Productive replication of Vif-chimeric HIV-1 in feline cells. J Virol (2010) 0.99
Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J Virol (2010) 0.97
Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity. J Virol (2003) 0.95
Feline immunodeficiency virus Vif localizes to the nucleus. J Virol (2000) 0.90
Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. J Virol (2001) 0.83
Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infections. Virus Res (2007) 0.78
Accessory genes confer a high replication rate to virulent feline immunodeficiency virus. J Virol (2013) 0.77
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (1988) 10.69
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (1988) 10.15
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
Molecular cloning and characterization of avian sarcoma virus circular DNA molecules. J Virol (1980) 7.37
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57
Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc Natl Acad Sci U S A (1987) 5.65
Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev (1989) 4.63
Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 4.57
Location and function of retroviral and SV40 sequences that enhance biochemical transformation after microinjection of DNA. Cell (1983) 4.53
Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol (1997) 4.19
Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev (1988) 3.51
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc Natl Acad Sci U S A (1987) 3.47
Molecular cloning of AIDS-associated retrovirus. Nature (1985) 3.16
Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus. Science (1986) 3.11
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (1988) 3.07
Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology (1996) 2.83
AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science (1986) 2.34
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol (1993) 2.26
Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science (1989) 2.25
Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol (1989) 2.21
Sequence relationships of type D retroviruses which cause simian acquired immunodeficiency syndrome. Virology (1987) 2.04
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology (1994) 1.94
Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol (1989) 1.88
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol (1990) 1.86
Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res Hum Retroviruses (2001) 1.82
Animal models of AIDS. FASEB J (1989) 1.82
Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr Biol (1996) 1.81
Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology (1986) 1.81
Distinct subsets of retroviruses encode dUTPase. J Virol (1992) 1.80
Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J Virol (1991) 1.71
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol (1993) 1.68
Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. J Virol (1990) 1.59
Simian foamy virus type 1 is a retrovirus which encodes a transcriptional transactivator. J Virol (1990) 1.58
Replication and regulation of primate foamy viruses. Virology (1991) 1.57
Transactivation of human immunodeficiency virus by herpesviruses. Oncogene (1987) 1.57
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res Hum Retroviruses (1990) 1.56
Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J Virol (1990) 1.49
Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology (1992) 1.42
Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum Retroviruses (1994) 1.40
Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol (1992) 1.38
Identification of the simian foamy virus transcriptional transactivator gene (taf). J Virol (1991) 1.36
Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef. J Virol (2000) 1.29
Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. J Med Primatol (1992) 1.26
Cellular factors regulate transactivation of human immunodeficiency virus type 1. J Virol (1991) 1.24
Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques. Virology (1998) 1.24
Relationship of the env genes and the endonuclease domain of the pol genes of simian foamy virus type 1 and human foamy virus. J Virol (1990) 1.23
Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques. J Virol (1998) 1.23
Generation of hybrid human immunodeficiency virus by homologous recombination. Proc Natl Acad Sci U S A (1989) 1.23
In vitro macrophage tropism of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). Virology (1991) 1.20
Simian immunodeficiency viruses and their relationship to the human immunodeficiency viruses. AIDS (1988) 1.18
Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J Infect Dis (1998) 1.16
Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma. Cancer Res (1986) 1.14
Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS (1989) 1.13
Nucleotide sequence and molecular analysis of the rhesus cytomegalovirus immediate-early gene and the UL121-117 open reading frames. Virology (1996) 1.13
Integration and expression of several molecular forms of Rous sarcoma virus DNA used for transfection of mouse cells. Mol Cell Biol (1984) 1.12
The nef gene of simian immunodeficiency virus SIVmac1A11. J Virol (1992) 1.11
cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1. J Virol (1992) 1.10
Characterization of the internal promoter of simian foamy viruses. J Virol (1994) 1.06
Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat. Virology (1989) 1.05
SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques. Virology (1999) 1.02
Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections. AIDS (1997) 1.00
Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SIV-positive and SIV-negative rhesus macaques. J Med Primatol (2004) 1.00
Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA. Virology (1991) 0.98
Analysis of the rhesus cytomegalovirus immediate-early gene promoter. Virology (1993) 0.98
The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proc Natl Acad Sci U S A (1996) 0.98
Regulatory elements in the long terminal repeat (LTR) of simian foamy virus type 3 (SFV-3). Virology (1993) 0.97
The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene. J Virol (1996) 0.97
Human immunodeficiency virus-associated vasculopathy in transgenic mice. J Virol (1997) 0.96
The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques. J Virol (2000) 0.96
Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone. Virology (1997) 0.94
Molecular biology of HIV. AIDS (1988) 0.93
Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Virology (2000) 0.93
Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope. AIDS (1998) 0.89
Cloning and characterization of rhesus cytomegalovirus glycoprotein B. J Gen Virol (1997) 0.88
Multi-step pathogenesis of AIDS--role of cytomegalovirus. Res Immunol (1991) 0.86
Molecular interactions of cytomegalovirus and the human and simian immunodeficiency viruses. J Med Primatol (1990) 0.83
Nef and the Nef-associated kinase. Res Virol (1997) 0.82
Transactivation of the two promoters of SFV-3 by different mechanisms. Virology (1996) 0.81
Molecular interactions between human immunodeficiency virus type 1 and human cytomegalovirus. Ann N Y Acad Sci (1990) 0.81
Characterization of rhesus macaque B-lymphoblastoid cell lines infected with simian type D retrovirus. AIDS Res Hum Retroviruses (1991) 0.80
The requirement for Vif of SIVmac is cell-type dependent. J Gen Virol (1996) 0.80
Simian retrovirus vaccines: simian retrovirus and simian immunodeficiency lentivirus. AIDS Res Hum Retroviruses (1996) 0.79
Transgenic dissection of HIV genes involved in lymphoid depletion. J Clin Invest (1997) 0.79
Homologous recombination between human immunodeficiency viral DNAs in cultured human cells: analysis of the factors influencing recombination. Biochem Biophys Res Commun (1988) 0.78
In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): correlation to in vivo outcome. J Med Primatol (1998) 0.78
A proposal for immunotherapy of HIV seropositive healthy individuals using an HIV envelope protein devoid of CD4 binding activity. AIDS Res Hum Retroviruses (1990) 0.77
Preliminary molecular characterization of a human immunodeficiency virus (HIV-I) associated with neuropathology. Ann Neurol (1988) 0.75